Company Intelligence
Medium Biosciences
Medium Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized AI-designed Affinity Reagents technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- San Francisco, United States
- Website
- medium.bio
- Founded
- 2021
- Employees
- 6
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Medium Biosciences is a Healthcare AI company based in San Francisco, United States, founded in 2021.
Medium Biosciences develops AI-designed Affinity Reagents.
What it builds
AI-designed Affinity Reagents
Why It Matters
Medium Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized AI-designed Affinity Reagents technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Medium Biosciences
Explore Medium Biosciences by Medium Biosciences. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Medium Biosciences
Industry
Products
Capabilities
- AI-designed Affinity Reagents
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Medium Biosciences do?
Medium Biosciences specializes in artificial intelligence, developing AI-designed Affinity Reagents to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Medium Biosciences based and when was it founded?
Medium Biosciences is based in United States and was founded in 2021.
What are the main products offered by Medium Biosciences?
The flagship platform from Medium Biosciences is AI-designed Affinity Reagents, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Medium Biosciences?
Medium Biosciences primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.